Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-22

Clinical Trial Update: IMT for Primary Clostridium Difficile Infection [Phase 2, Phase 3]

View source ↗

Summary

A clinical trials update for IMT in primary Clostridium difficile infection covering Phase 2 and Phase 3, with the study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IMT

Snippet

Sponsor: Oslo University Hospital | Conditions: Clostridium Difficile Infection | Phase 2, Phase 3 | Status: TERMINATED